This is VAERS ID 272535

Administered by: Private       Purchased by: Other
Symptoms: Blood test, Immediate post-injection reaction, Injection site erythema, Injection site nodule, Laboratory test, Nerve conduction studies, Nerve injury, Nuclear magnetic resonance imaging, Pain, Similar reaction on previous exposure to drug
SMQs:, Accidents and injuries (narrow), Extravasation events (injections, infusions and implants) (broad), Hypersensitivity (narrow)

Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: UNK; GLUCOPHAGE
Current Illness: Diabetes; Drug hypersensitivity
Preexisting Conditions: UNK
Diagnostic Lab Data: UNK; magnetic laboratory; diagnostic laboratory; nerve conduction study
CDC Split Type: WAES0701USA04555

Write-up: This is in follow-up to report(s) previously submitted on 2/14/2007; 7/6/2007. Information has been received from a nurse concerning a 19 year old female with diabetes and a reaction to ROBITUSSIN who in mid-December 2006, was vaccinated intramuscularly with a second dose of GARDASIL. Concomitant therapy included GLUCOPHAGE. On an unspecified date, the patient developed immediate redness at the injection site and a knot was noticed at the injection site 1 to 2 days post injection. The patient also experienced pain "right after the injection." The patient''s mother noted that the pain following the first dose was not as severe as the pain experienced after the second dose. The nurse reported that the patient did not see her family physician and the family physician suspected "nerve damage." It was not specified whether or not the patient had a reaction the first time she was vaccinated with HPV VLP vaccine (yeast). The nurse reported that they were following up with the patient to make sure she was okay. On an unspecified date, magnetic resonance imaging (MRI), blood work and a nerve conduction study were performed (results not provided) to make sure there was no nerve damage. Unspecified medical attention was sought. At the time of this report, the patient was still experiencing pain "some days worse than others". No product quality complaint was involved. Additional information is not expected.